• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Addex Therapeutics Ltd

+ Add to Watchlist


2.02 CHF 0.09 4.66%

As of 11:43:41 ET on 04/17/2014.

Snapshot for Addex Therapeutics Ltd (ADXN)

Open: 1.93 Day's Range: 1.93 - 2.10 Volume: 27,700
Previous Close: 1.93 52wk Range: 1.85 - 7.26 1-Yr Rtn: -68.92%

Stock Chart for ADXN

No chart data available.
  • ADXN:SW 2.02
  • 1D
  • 1M
  • 1Y
Interactive ADXN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADXN

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -3.4100
Est. EPS (CHF) (12/2013) -1.8450
Est. PEG Ratio -
Market Cap (M CHF) 20.55
Shares Outstanding (M) 10.17
30 Day Average Volume 24,621
Price/Book (mrq) 1.0705
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADXN

No data available

Company Profile & Key Executives for ADXN

Addex Therapeutics Ltd is a biotechnology company. The Company discovers and develops a type of orally available small molecule drugs, called allosteric modulators, to treat a broad range of diseases.

Andre J MuellerNon Exec Chair/Interim CEO/Interim PresGraham DixonChief Scientific Ofcr/Head:Rsch
Sonia PoliHead:Non-Clinical Development
More Company Profile & Key Executives for ADXN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil